NEW YORK, Oct. 21, 2016 /PRNewswire/ -- The multidistrict litigation established earlier this month for all federally-filed ovarian cancer lawsuits involving talcum powder products marketed by Johnson & Johnson will officially get underway in November. According to an Order issued in the U.S. District Court, District of New Jersey, on October 20th, the Court will convene an Organizational Conference on Thursday, November 17th at 10:00 a.m. to address "housekeeping" issues in individual cases. The Order further stipulates that the parties are to submit a Status Report by November 10th that includes, among other things, suggestions as to lead and liaison counsel, as well as suggestions for agenda items to be discussed at the conference. (In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation – MDL No.2738)
"Our Firm has heard from numerous women, as well as their families, who are interested in pursuing a talcum powder lawsuit against Johnson & Johnson following an ovarian cancer diagnosis. We are eager for the multidistrict litigation to get underway, and will be monitoring its progress closely," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer following years of regular, repeated use of talc-based products for feminine hygiene purposes.
Talcum Powder Litigation
The federal talcum powder litigation was established on October 4th by an Order of the U.S. Judicial Panel for Multidistrict Litigation. Thirty-seven cases are already pending in the District of New Jersey, with additional cases awaiting transfer. Any future ovarian cancer claims filed in federal courts against Johnson & Johnson are likely to be transferred there as well.
Johnson & Johnson faces more than 1,800 talcum powder lawsuits in courts around the country. All of the cases put forth similar allegations regarding the potential for the company's Baby Powder and Shower-to-Shower products to contribute to the development of ovarian cancer when applied to the female genitals over a long period of time. Plaintiffs cite numerous studies dating back to the 1970s that suggest a link between talcum powder and ovarian cancer, and fault Johnson & Johnson for allegedly failing to provide any warnings to consumers.
Two additional centralized talcum powder litigations are already underway in St. Louis, Missouri and New Jersey Superior Court. In April, a St. Louis jury awarded $55 million in compensatory and punitive damages to an ovarian cancer victim who used Johnson & Johnson's talc-based powders for nearly 40 years as part of her feminine hygiene routine. In February, another Missouri trial ended with an award of $72 million for the family of a woman who died from the disease after using the company's talc products for more than 30 years. The proceeding is currently conducting its third trial. (Case No. 1422-CC09012-01)
Women who were diagnosed with ovarian cancer following the long-term, regular use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/talcum-powder-lawsuit-news-federal-court-schedules-first-conference-for-ovarian-cancer-litigation-bernstein-liebhard-llp-reports-300349229.html
SOURCE Bernstein Liebhard LLP